Good Clinical Practices Are Not Optional: The FDA’s Commitment to Human Subject Protections and Gold Standard Science in an Era of Global Clinical Research

Summary

The FDA reaffirms its commitment to Good Clinical Practices (GCP) as a scientific and ethical foundation for regulatory decisions, emphasizing that GCP compliance is not optional bureaucratic formality but essential for human subject protections and quality science in global clinical research.